206 related articles for article (PubMed ID: 23709276)
1. The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease.
Wu D; Hu Y; Tong S; Williams BR; Smyth GK; Gantier MP
RNA; 2013 Jul; 19(7):876-88. PubMed ID: 23709276
[TBL] [Abstract][Full Text] [Related]
2. Normalization of Affymetrix miRNA Microarrays for the Analysis of Cancer Samples.
Wu D; Gantier MP
Methods Mol Biol; 2016; 1375():1-10. PubMed ID: 25971910
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
[TBL] [Abstract][Full Text] [Related]
4. Stop the dicing in hematopoiesis: what have we learned?
Alemdehy MF; Erkeland SJ
Cell Cycle; 2012 Aug; 11(15):2799-807. PubMed ID: 22801545
[TBL] [Abstract][Full Text] [Related]
5. Reduced DICER1 elicits an interferon response in endometrial cancer cells.
Chiappinelli KB; Haynes BC; Brent MR; Goodfellow PJ
Mol Cancer Res; 2012 Mar; 10(3):316-25. PubMed ID: 22252463
[TBL] [Abstract][Full Text] [Related]
6. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
Liao CC; Ho MY; Liang SM; Liang CM
Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
[TBL] [Abstract][Full Text] [Related]
7. miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.
Wang Y; Bao W; Liu Y; Wang S; Xu S; Li X; Li Y; Wu S
Cell Death Dis; 2018 May; 9(5):447. PubMed ID: 29670086
[TBL] [Abstract][Full Text] [Related]
8. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.
Galka-Marciniak P; Urbanek-Trzeciak MO; Nawrocka PM; Kozlowski P
Nucleic Acids Res; 2021 Jan; 49(2):601-620. PubMed ID: 33406242
[TBL] [Abstract][Full Text] [Related]
9. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation.
Gantier MP; McCoy CE; Rusinova I; Saulep D; Wang D; Xu D; Irving AT; Behlke MA; Hertzog PJ; Mackay F; Williams BR
Nucleic Acids Res; 2011 Jul; 39(13):5692-703. PubMed ID: 21447562
[TBL] [Abstract][Full Text] [Related]
10. Widespread regulation of miRNA biogenesis at the Dicer step by the cold-inducible RNA-binding protein, RBM3.
Pilotte J; Dupont-Versteegden EE; Vanderklish PW
PLoS One; 2011; 6(12):e28446. PubMed ID: 22145045
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells.
Fan M; Krutilina R; Sun J; Sethuraman A; Yang CH; Wu ZH; Yue J; Pfeffer LM
J Biol Chem; 2013 Sep; 288(38):27480-27493. PubMed ID: 23921383
[TBL] [Abstract][Full Text] [Related]
12. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.
Rowley JW; Chappaz S; Corduan A; Chong MM; Campbell R; Khoury A; Manne BK; Wurtzel JG; Michael JV; Goldfinger LE; Mumaw MM; Nieman MT; Kile BT; Provost P; Weyrich AS
Blood; 2016 Apr; 127(14):1743-51. PubMed ID: 26773046
[TBL] [Abstract][Full Text] [Related]
13. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
14. A precursor microRNA in a cancer cell nucleus: get me out of here!
Melo SA; Esteller M
Cell Cycle; 2011 Mar; 10(6):922-5. PubMed ID: 21346411
[TBL] [Abstract][Full Text] [Related]
15. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
RamÃrez-Moya J; Wert-Lamas L; Riesco-Eizaguirre G; Santisteban P
Oncogene; 2019 Jul; 38(27):5486-5499. PubMed ID: 30967628
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.
Li X; Zhang Y; Shi Y; Dong G; Liang J; Han Y; Wang X; Zhao Q; Ding J; Wu K; Fan D
J Cell Mol Med; 2011 Sep; 15(9):1887-95. PubMed ID: 21029372
[TBL] [Abstract][Full Text] [Related]
17. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
18. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
Czubak K; Lewandowska MA; Klonowska K; Roszkowski K; Kowalewski J; Figlerowicz M; Kozlowski P
Oncotarget; 2015 Sep; 6(27):23399-416. PubMed ID: 26156018
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of DICER1-mutated pituitary blastoma.
Nadaf J; de Kock L; Chong AS; Korbonits M; Thorner P; Benlimame N; Fu L; Peet A; Warner J; Ploner O; Shuangshoti S; Albrecht S; Hamel N; Priest JR; Rivera B; Ragoussis J; Foulkes WD
Acta Neuropathol; 2021 Jun; 141(6):929-944. PubMed ID: 33644822
[TBL] [Abstract][Full Text] [Related]
20. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
